Seroconversion against SARS‐CoV‐2 occurred after the recovery in patients with COVID‐19

Little is known about the protective immunity for coronavirus disease 2019 (COVID‐19) while the demand for COVID‐19 serology tests is increasing.

Saved in:
Bibliographic Details
Published inJournal of Medical Virology Vol. 93; no. 2; pp. 692 - 694
Main Authors Yamamoto, Shinya, Saito, Makoto, Nagai, Etsuko, Toriuchi, Keiko, Nagai, Hiroyuki, Yotsuyanagi, Hiroshi, Nakagama, Yu, Kido, Yasutoshi, Adachi, Eisuke
Format Journal Article Web Resource
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.02.2021
Wiley Subscription Services, Inc
Subjects
Adult
Aged
Antibodies, Viral - blood
Convalescence
COVID-19
COVID-19 - immunology
Female
Humans
Immunoglobulin G - blood
Immunoglobulin M - blood
Longitudinal Studies
Male
Middle Aged
Retrospective Studies
SARS-CoV-2 - immunology
Seroconversion
Severe acute respiratory syndrome coronavirus 2
Virology
Online AccessGet full text

Cover

More Information
Summary:Little is known about the protective immunity for coronavirus disease 2019 (COVID‐19) while the demand for COVID‐19 serology tests is increasing.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.26495